Publication:
Disability Accrual in Primary and Secondary Progressive Multiple Sclerosis

dc.authorscopusid57201747942
dc.authorscopusid57195070200
dc.authorscopusid57194166645
dc.authorscopusid56580275300
dc.authorscopusid57216934710
dc.authorscopusid57239633800
dc.authorscopusid16314591800
dc.authorwosidSlee, Mark/J-4731-2015
dc.authorwosidHorakova, Dana/D-4649-2011
dc.authorwosidGouider, Riadh/Aax-2634-2020
dc.authorwosidRoos, Izanne/Abo-3767-2022
dc.authorwosidLugaresi, Alessandra/C-7743-2012
dc.authorwosidBergamaschi, Roberto/I-1984-2015
dc.authorwosidTürkoğlu, Recai/B-9336-2014
dc.contributor.authorHarding-Forrester, Sam
dc.contributor.authorRoos, Izanne
dc.contributor.authorNguyen, Ai-Lan
dc.contributor.authorMalpas, Charles B.
dc.contributor.authorDiouf, Ibrahima
dc.contributor.authorMoradi, Nahid
dc.contributor.authorKalincik, Tomas
dc.contributor.authorIDSlee, Mark/0000-0003-4323-2453
dc.contributor.authorIDKappos, Ludwig/0000-0003-4175-5509
dc.contributor.authorIDRoos, Izanne/0000-0003-0371-3666
dc.contributor.authorIDMacdonell, Richard/0000-0001-6604-3968
dc.contributor.authorIDTurkoglu, Recai/0000-0001-9724-851X
dc.contributor.authorIDVan Wijmeersch, Bart/0000-0003-0528-1545
dc.date.accessioned2025-12-11T01:39:23Z
dc.date.issued2023
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Harding-Forrester, Sam; Roos, Izanne; Nguyen, Ai-Lan; Malpas, Charles B.; Diouf, Ibrahima; Moradi, Nahid; Sharmin, Sifat; Kalincik, Tomas] Univ Melbourne, Dept Med, CORe, Melbourne, Vic, Australia; [Roos, Izanne; Nguyen, Ai-Lan; Malpas, Charles B.; Diouf, Ibrahima; Moradi, Nahid; Sharmin, Sifat; Kalincik, Tomas] Royal Melbourne Hosp, Dept Neurol, Ctr Neuroimmunol, Parkville, Vic, Australia; [Izquierdo, Guillermo; Eichau, Sara] Hosp Univ Virgen Macarena, Multiple Sclerosis Unit, Seville, Spain; [Patti, Francesco] Univ Catania, Dept Surg & Med Sci & Adv Technol GF Ingrassia, Neurosci, Catania, Italy; [Horakova, Dana; Kubala Havrdova, Eva] Charles Univ Prague, Dept Neurol, Prague, Czech Republic; [Horakova, Dana; Kubala Havrdova, Eva] Charles Univ Prague, Ctr Clin Neurosci, Fac Med 1, Prague, Czech Republic; [Prat, Alexandre; Girard, Marc; Duquette, Pierre] Univ Montreal, Ctr Hosp, Montreal, PQ, Canada; [Prat, Alexandre] Univ Montreal, Dept Neurosci, Montreal, PQ, Canada; [Girard, Marc; Duquette, Pierre] Univ Montreal, Fac Med, Montreal, PQ, Canada; [Maison, Francois Grand] Neuro Rive Sud, Longueuil, PQ, Canada; [Onofrj, Marco] Gabriele dAnnunzio Univ Chieti Pescara, Dept Neurosci Imaging & Clin Sci, Chieti, Italy; [Lugaresi, Alessandra] IRCCS Ist Sci Neurol Bologna, UOSI Riabilitaz Sclerosi Multipla, Bologna, Italy; [Lugaresi, Alessandra] Univ Bologna, Dipartimento Sci Biomed & Neuromotorie, Bologna, Italy; [Grammond, Pierre] Quebec Ctr Rech, Ctr Integre Sante & Serv Soc Chaudiere Appalaches, Levis, PQ, Canada; [Ozakbas, Serkan] Dokuz Eylul Univ, Dept Neurol, Izmir, Turkiye; [Amato, Maria Pia] Univ Florence, Dept Neurol Siences, Florence, Italy; [Amato, Maria Pia] IRCCS Fdn Don Carlo Gnocchi, Florence, Italy; [Gerlach, Oliver] Zuyderland Med Ctr, Dept Neurol, Sittard Geleen, Netherlands; [Sola, Patrizia] Azienda Osped Univ Modena, Neurol Unit, Modena, Italy; [Ferraro, Diana] Azienda Osped Univ Modena, Dept Neurosci, Modena, Italy; [Ferraro, Diana] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Modena, Italy; [Buzzard, Katherine; Skibina, Olga] Box Hill Hosp, Dept Neurol, Box Hill, Vic, Australia; [Lechner-Scott, Jeannette] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW, Australia; [Lechner-Scott, Jeannette] John Hunter Hosp, Dept Neurol, Newcastle, NSW, Australia; [Alroughani, Raed] Al Amiri Hosp, Dept Med, Kuwait, Kuwait; [Boz, Cavit] Karadeniz Tech Univ, Dept Neurol, Trabzon, Turkiye; [Van Pesch, Vincent] Clin Univ St Luc, Dept Neurol, Brussels, Belgium; [Cartechini, Elisabetta] Azienda Sanit Unica Regionale Marche AV3, UOC Neurol, Macerata, Italy; [Terzi, Murat] Ondokuz Mayis Univ, Samsun, Turkiye; [Maimone, Davide] Osped Garibaldi, UO Neurol, Catania, Italy; [Ramo-Tello, Cristina] Hosp Badalona Germans Trias & Pujol, Dept Neurosci, Barcelona, Spain; [Yamout, Bassem] Amer Univ Beirut, Nehme & Therese Tohme Multiple Sclerosis Ctr, Beirut, Lebanon; [Yamout, Bassem] Amer Univ Beirut, Dept Neurol, Beirut, Lebanon; [Khoury, Samia Joseph] Amer Univ Beirut, Beirut, Lebanon; [La Spitaleri, Daniele] AORN San Giuseppe Moscati, UOC Neurol & Stroke, Avellino, Italy; [Sa, Maria Jose] Ctr Hosp Sao Joao, Dept Neurol, Porto, Portugal; [Sa, Maria Jose] Fernando Pessoa Univ, Hlth Sci Fac, Porto, Portugal; [Blanco, Yolanda] Hosp Clin Barcelona, Barcelona, Spain; [Granella, Franco] Univ Parma, Multiple Sclerosis Ctr, Neurosci, Parma, Italy; [Slee, Mark] Flinders Med Ctr, Dept Neurol, Adelaide, SA, Australia; [Butler, Ernest] Monash Med Ctr Clayton, Dept Neurol, Clayton, Vic, Australia; [Sidhom, Youssef] Hop Razi, Dept Neurol, La Manouba, Tunisia; [Gouider, Riadh] Razi Hosp, Dept Neurol, Rasht, Gilan, Iran; [Bergamaschi, Roberto] Neurol Inst C Mondino, Multiple Sclerosis Ctr, Pavia, Italy; [Karabudak, Rana] Hacettepe Univ, Dept Neurol, Fac Med, Ankara, Turkiye; [Ampapa, Radek] Nemocnice Jihlava, Dept Neurol, Jihlava, Czech Republic; [Sanchez-Menoyo, Jose Luis] Hosp Galdakao Usansolo, Dept Neurol, Galdakao, Pais Vasco, Spain; [Prevost, Julie] Ctr Integre Sante & Serv Sociaux Laurentides Poin, St Jerome, PQ, Canada; [Castillo-Trivino, Tamara] Donostia Univ Hosp, Dept Neurol, San Sebastian, Spain; [McCombe, Pamela A.] Univ Queensland, UQCCR, St Lucia, Qld, Australia; [Macdonell, Richard] Austin Hlth, Dept Neurol, Heidelberg, Vic, Australia; [Laureys, Guy; Van Hijfte, Liesbeth] Univ Hosp Ghent, Dept Neurol, Oost Vlaanderen, Belgium; [Oh, Jiwon] St Michaels Hosp, Dept Med, Div Neurol, Toronto, ON, Canada; [Altintas, Ayse] Koc Univ, Dept Neurol, Istanbul, Turkiye; [Altintas, Ayse] Koc Univ, Res Ctr Translat Med KUTTAM, Istanbul, Turkiye; [de Gans, Koen] Groene Hart Ziekenhuis, Dept Neurol, Zuid Holland, Netherlands; [Turkoglu, Recai] Haydarpasa Numune Training & Res Hosp, Dept Neurol, Istanbul, Turkiye; [van der Walt, Anneke] Monash Univ, Cent Clin Sch, Multiple Sclerosis & Neuroimmunol Unit, Melbourne, Vic, Australia; [Butzkueven, Helmut] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia; [Butzkueven, Helmut] Alfred, Dept Neurol, Melbourne, Vic, Australia; [Vucic, Steve] Westmead Hosp, Dept Neurol, Westmead, NSW, Australia; [Barnett, Michael] Univ Sydney, Brain & Mind Ctr, Sydney, NSW, Australia; [Cristiano, Edgardo] Hosp Italiano Buenos Aires, Ctr Esclerosis Multiple Buenos Aires, Buenos Aires, DF, Argentina; [Hodgkinson, Suzanne] Liverpool Hosp, Dept Neurol, Liverpool, NSW, Australia; [Iuliano, Gerardo] Osped Riuniti Salerno, Salerno, Italy; [Kappos, Ludwig] Univ Basel Hosp, Neurol Clin & Policlin, Dept Med, Basel, Switzerland; [Kappos, Ludwig] Univ Basel Hosp, Neurol Clin & Policlin, Dept Biomed, Basel, Switzerland; [Kappos, Ludwig] Univ Basel Hosp, Clin Res, Basel, Switzerland; [Kappos, Ludwig] Univ Basel Hosp, Res Ctr Clin Neuroimmunol & Neurosci, Basel, Switzerland; [Shaygannejad, Vahid] Isfahan Univ Med Sci, Dept Neurol, Esfahan, Iran; [Soysal, Aysun] Bakirkoy Res & Training Hosp Psychiat Neurol & Ne, Dept Neurol, Istanbul, Turkiye; [Weinstock-Guttman, Bianca] SUNY Buffalo, Dept Neurol, Jacobs Sch Med & Biomed Sci, Buffalo, NY USA; [Van Wijmeersch, Bart] Hasselt Univ, Univ MS Centrum, Hasselt Pelt, Belgium; [Van Wijmeersch, Bart] Rehabil & MS Ctr, Pelt, Belgiumen_US
dc.descriptionSlee, Mark/0000-0003-4323-2453; Kappos, Ludwig/0000-0003-4175-5509; Roos, Izanne/0000-0003-0371-3666; Macdonell, Richard/0000-0001-6604-3968; Turkoglu, Recai/0000-0001-9724-851X; Van Wijmeersch, Bart/0000-0003-0528-1545; Barnett, Michael/0000-0002-2156-8864; Malpas, Charles/0000-0003-0534-3718; Sánchez Menoyo, José Luis/0000-0003-2634-8294; Diouf, Ibrahima/0000-0002-9672-303X; Prat, Alexane/0000-0001-6188-0580; Kuhle, Jens/0000-0002-6963-8892; Moradi, Nahid/0000-0001-6253-4487; Lugaresi, Alessana/0000-0003-2902-5589; Nguyen, Ai-Lan/0000-0003-0378-6005; Gouider, Riadh/0000-0001-9615-3797;en_US
dc.description.abstractBackgroundSome studies comparing primary and secondary progressive multiple sclerosis (PPMS, SPMS) report similar ages at onset of the progressive phase and similar rates of subsequent disability accrual. Others report later onset and/or faster accrual in SPMS. Comparisons have been complicated by regional cohort effects, phenotypic differences in sex ratio and management and variable diagnostic criteria for SPMS. MethodsWe compared disability accrual in PPMS and operationally diagnosed SPMS in the international, clinic-based MSBase cohort. Inclusion required PPMS or SPMS with onset at age >= 18 years since 1995. We estimated Andersen-Gill hazard ratios for disability accrual on the Expanded Disability Status Scale (EDSS), adjusted for sex, age, baseline disability, EDSS score frequency and drug therapies, with centre and patient as random effects. We also estimated ages at onset of the progressive phase (Kaplan-Meier) and at EDSS milestones (Turnbull). Analyses were replicated with physician-diagnosed SPMS. ResultsIncluded patients comprised 1872 with PPMS (47% men; 50% with activity) and 2575 with SPMS (32% men; 40% with activity). Relative to PPMS, SPMS had older age at onset of the progressive phase (median 46.7 years (95% CI 46.2-47.3) vs 43.9 (43.3-44.4); p<0.001), greater baseline disability, slower disability accrual (HR 0.86 (0.78-0.94); p<0.001) and similar age at wheelchair dependence. ConclusionsWe demonstrate later onset of the progressive phase and slower disability accrual in SPMS versus PPMS. This may balance greater baseline disability in SPMS, yielding convergent disability trajectories across phenotypes. The different rates of disability accrual should be considered before amalgamating PPMS and SPMS in clinical trials.en_US
dc.description.sponsorshipNational Health and Medical Research Council of Australia [1129189, 1140766]; Biogen; CSL; Merck; Novartis; Roche; Teva; Sanofien_US
dc.description.sponsorshipThis study was financially supported by the National Health and Medical Research Council of Australia (1129189, 1140766). The MS Base Foundation is a not- for- profit organisation that has received support from Biogen, CSL, Merck, Novartis, Roche, Sanofi and Teva; this study was conducted independently of the sponsors.en_US
dc.description.woscitationindexScience Citation Index Expanded
dc.identifier.doi10.1136/jnnp-2022-330726
dc.identifier.endpage717en_US
dc.identifier.issn0022-3050
dc.identifier.issn1468-330X
dc.identifier.issue9en_US
dc.identifier.pmid37068931
dc.identifier.scopus2-s2.0-85160248113
dc.identifier.scopusqualityQ1
dc.identifier.startpage707en_US
dc.identifier.urihttps://doi.org/10.1136/jnnp-2022-330726
dc.identifier.urihttps://hdl.handle.net/20.500.12712/45199
dc.identifier.volume94en_US
dc.identifier.wosWOS:000989489100001
dc.identifier.wosqualityQ1
dc.language.isoenen_US
dc.publisherBMJ Publishing Groupen_US
dc.relation.ispartofJournal of Neurology Neurosurgery and Psychiatryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectMultiple Sclerosisen_US
dc.titleDisability Accrual in Primary and Secondary Progressive Multiple Sclerosisen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files